LYNDA SMITH HARRIS: Open Payments
NPI 1831272947 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 36 payments from 9 companies in 2025. Trend: 2023 $1,197 · 2024 $1,786 · 2025 $742
Food & beverage: $742
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 20 | $384 |
| Lundbeck LLC | 3 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $64 |
| Otsuka America Pharmaceutical, Inc. | 2 | $57 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| Alkermes, Inc. | 1 | $33 |
| E.R. Squibb & Sons, L.L.C. | 2 | $29 |
| ABBVIE INC. | 1 | $22 |
| Orexo US, Inc. | 1 | $15 |
Products named: INGREZZA, ABILIFY MAINTENA, CAPLYTA, Auvelity, ARISTADA, COBENFY, MAVYRET, Zubsolv.
Industry payments across NY — which companies pay providers there.
